Role of the endothelium and blood stasis in the appearance of varicose veins

International Angiology

Volumn 21, Issue 2 SUPPL. 1, 2002, Pages 18-25

  Michiels, C ^a   Bouaziz, N ^a   Remacle, J ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Endothelium, vascular; Inflammation mediators; Ischemia; Varicose veins, etiology; Varicose veins,therapy

Indexed keywords

1,2 NAPHTHOQUINONE DERIVATIVE; ADENOSINE TRIPHOSPHATE; BASIC FIBROBLAST GROWTH FACTOR; DIOSMIN; ESCIN; GINKGO BILOBA EXTRACT; GROWTH FACTOR; MATRIX METALLOPROTEINASE; MELILOTUS EXTRACT; MONOXERUTIN; PROCYANIDOL OLIGOMER; PROSTAGLANDIN F2 ALPHA; RUSCUS ACULEATUS EXTRACT; VASOACTIVE AGENT;

CAPILLARY PERMEABILITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC VEIN INSUFFICIENCY; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENDOTHELIUM LESION; EXTRACELLULAR MATRIX; HEMOSTASIS; HISTOPATHOLOGY; HUMAN; INTIMA; ISCHEMIA; LEUKOCYTE ACTIVATION; MEDIATOR; NEUTROPHIL CHEMOTAXIS; PHENOTYPE; RESPIRATORY CHAIN; REVIEW; SMOOTH MUSCLE FIBER; VARICOSIS; VASCULAR ENDOTHELIUM; VEIN PERMEABILITY; VEIN TONE; VEIN WALL;

BLOOD CIRCULATION; CELL ADHESION; CELL HYPOXIA; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOCYTES; NEUTROPHILS; PLANT EXTRACTS; SAPHENOUS VEIN; VARICOSE VEINS;

EID: 0036625733     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Ibrahim S, MacPherson DR, Goldhaber SZ. Chronic venous insufficiency: mechanisms and management. Am Heart J 1996; 132:856-60.
2. Alguire PC, Mathes BM. Chronic venous insufficiency and venous ulceration. J Gen Intern Med 1997; 12: 374-83.
3. Evans CJ, Fowkes FG, Hajivassiliou CA, Harper DR, Ruckley CV. Epidemiology of varicose veins. A review. Int Angiol 1994; 13:263-70.
4. Krijnen RM, de Boer EM, Bruynzeel DR Epidemiology of venous disorders in the general and occupational populations. Epidemiol Rev 1997; 19:294-309.
5. De Backer G. Epidemiology of chronic venous insufficiency. Angiology 1997; 48:569-76.
6. Lengyel I, Acsady G. Histomorphological and pathobiochemical changes of varicose veins. A possible explanation of the development of varicosis. Acta Morphol Hung 1990; 38:259-67.
7. Charles AK, Gresham GA. Histopathological changes in venous grafts and in varicose and non-varicose veins. J Clin Pathol 1993; 46:603-6.
8. Porto LC, da Silveira PR, de Carvalho JJ, Panico MD. Connective tissue accumulation in the muscle layer in normal and varicose saphenous veins. Angiology 1995; 46:243-9.
9. Gandhi RH, Irizarry E, Nackman GB, Halpern VJ, Mulcare RJ, Tilson MD. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993; 18:814-20.
10. Travers JP, Brookes CE, Evans J, Baker DM, Kent C, Makin GS et al. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996; 11:230-7.
11. Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol 2000; 192:105-12.
12. Badier-Commander C, Couvelard A, Henin D, Verbeuren T, Michel JB, Jacob MP. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol, in press.
13. Ross R, Bowen-Pope D, Raines EW, Faggiotto A. Endothelial injury: blood-vessel wall interactions. Ann N Y Acad Sci 1982; 401:260-4.
14. Michiels C, Arnould T, Thibaut-Vercruyssen R, Bouaziz N, Janssens D, Remacle J. Perfused human saphenous veins for the study of the origin of varicose veins: role of the endothelium and of hypoxia. Int Angiol 1997; 16:134-41.
15. McEwan AJ, McArdle CS. Effect of hydroxyethylrutosides on blood oxygen levels and venous insufficiency symptoms in varicose veins. Br Med J 1971; 2:138-41.
16. Mildenberger E, Siegel G, Versmold HT. Oxygen-dependent regulation of membrane potential and vascular tone of human umbilical vein. Am J Obstet Gynecol 1999; 181:696-700.
17. Arnould T, Michiels C, Janssens D, Delaive E, Remacle J. Hypoxia induces PMN adherence to umbilical vein endothelium. Cardiovasc Res 1995; 30:1009-16.
18. Niebes P. Physiologie de la veine variqueuse. Angiologie 1987; 3:3-11.
19. Thomas PR, Nash GB, Dormandy JA. Increased white cell trapping in the dependent legs of patients with chronic venous insufficiency. J Mal Vasc 1991; 16:35-7.
20. Ciuffetti G, Mannarino E, Paltriccia R, Malagigi V, Sergi F, Paulisch P et al. Leucocyte activity in chronic venous insufficiency. Int Angiol 1994; 13:312-6.
21. Shields DA, Andaz SK, Sarin S, Scurr JH, Coleridge Smith PD. Plasma elastase in venous disease. Br J Surg 1994; 81:1496-9.
22. Signorelli S, Arpaia G, Cimminiello C, Pennisi G, Borsetto M, Mazzullo M et al. Levels of the inhibitor of PMN-elastase in venous blood reflowing from chronically affected veins: the role of venous stasis. Int Angiol 1998; 17:49-52.
23. Michiels C, Arnould T, Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 2000; 1497: 1-10.
24. Arnould T, Michiels C, Remacle J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol 1993; 264:C1102-C10.
25. Ginis I, Mentzer SJ, Faller DV. Oxygen tension regulates neutrophil adhesion to human endothelial cells via an LFA-1-dependent mechanism. J Cell Physiol 1993; 157:569-78.
26. Milhoan KA, Lane TA, Bloor CM. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF Am J Physiol 1992; 263:H956-H62.
27. Michiels C, De Leener F, Arnould T, Dieu M, Remacle J. Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGE. Exp Cell Res 1994; 213:43-54.
28. Peschen M, Grenz H, Grothe C, Schopf E, Vanscheidt W. Patterns of epidermal growth factor receptor, basic fibroblast growth factor and transforming growth factor-β3 expression in skin with chronic venous insufficiency. Eur J Dermatol 1998; 8:334-8.
29. Vanhoutte PM, Corcaud S, de Montrion C. Venous disease: from pathophysiology to quality of life. Angiology 1997; 48:559-67.
30. Struckmann JR. Clinical efficacy of micronized purified flavonoid fraction: an overview. J Vasc Res 1999; 36:37-41.
31. Diehm C, Trampisch HJ, Lange S, Schmidt C. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency [see comments]. Lancet 1996; 347:292-4.
32. Henriet JP. Veno-lymphatic insufficiency. 4,729 patients undergoing hormonal and procyanidol oligomer therapy. Phlebologie 1993; 46:313-25.
33. Shoab SS, Porter JB, Scurr JH, Coleridge-Smith PD. Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot study. J Vasc Surg 2000; 31:456-61.
34. Janssens D, Michiels C, Guillaume G, Cuisinier B, Louagie Y, Remacle J. Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 33:7-11.
35. Boccalon H, Causse C, Yubero L. Comparative efficacy of a single daily dose of two capsules Cyclo 3 Fort in the morning versus a repeated dose of one capsule morning and noon. A one-month study. Int Angiol 1998; 17:155-60.
36. Unkauf M, Rehn D, Klinger J, de la Motte S, Grossmann K. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings. Arzneimittelforschung 1996; 46:478-82.
37. Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review. Arch Dermatol 1998; 134:1356-60.
38. Frick RW. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon. Angiology 2000; 51:197-205.
39. Roland IH, Bougelet C, Ninane N, Arnould T, Michiels C, Remacle J. Effect of hydroxyethylrutosides on hypoxia-induced neutrophil adherence to umbilical vein endothelium. Cardiovasc Drugs Ther 1998; 12:375-81.
40. Arnould T, Michiels C, Janssens D, Berna N, Remacle J. Effect of Ginkor Fort on hypoxia-induced neutrophil adherence to human saphenous vein endothelium. J Cardiovasc Pharmacol 1998; 31:456-63.
41. Bougelet C, Roland IH, Ninane N, Arnould T, Remacle J, Michiels C. Effect of aescine on hypoxia-induced neutrophil adherence to umbilical vein endothelium. Eur J Pharmacol 1998; 345:89-95.
42. Janssens D, Delaive E, Houbion A, Eliaers F, Remacle J, Michiels C. Effect of venotropic drugs on the respiratory activity of isolated mitochondria and in endothelial cells. Br J Pharmacol 2000; 130:1513-24.